RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,400.00
0.00 (0.00%)
At close: Apr 20, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 55.46 billion as of April 21, 2026. Its market cap has increased by 5.79% in one year.
Market Cap
55.46B
Enterprise Value
60.29B
Revenue
136.22B
Ranking
n/a
PE Ratio
11.83
Stock Price
6,400.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 55.46B, a decrease of -61.26%. That is a compound annual growth rate of -23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 55.46B | -13.51% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 85.82B |
| Hwail Pharmaceutical | 79.38B |
| Sinil Pharmaceutical | 73.72B |
| BL Pharmtech | 69.50B |
| Jin Yang Pharmaceutical | 62.81B |
| Kyung Nam Pharm | 60.10B |
| Korea Arlico Pharm | 56.71B |
| Eagle Veterinary Technology Co.,Ltd | 50.25B |